A profile of enzalutamide for the treatment of advanced castration resistant prostate cancer

Recent advances in understanding the mechanisms underlying the development and progression of castration resistant prostate cancer from androgen-sensitive prostate cancer have provided new avenues exploring efficacious therapies in a disease which is the second leading cause of cancer deaths among m...

Descripción completa

Detalles Bibliográficos
Autores principales: Greasley, Rosa, Khabazhaitajer, Mohammad, Rosario, Derek J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4472073/
https://www.ncbi.nlm.nih.gov/pubmed/26109877
http://dx.doi.org/10.2147/CMAR.S50585

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4472073/
https://www.ncbi.nlm.nih.gov/pubmed/26109877
http://dx.doi.org/10.2147/CMAR.S50585

Ejemplares similares